Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures

Journal of Surgical Oncology

Volumn 107, Issue 5, 2013, Pages 544-549

  Cannon, Robert ^a   Ellis, Susan ^a   Hayes, David ^b   Narayanan, Govindarajan ^c   Martin II, Robert C G ^a  

^a University of Louisville School of Medicine   (United States)

^b Baptist Hospital   (United States)

^c UNIVERSITY OF MIAMI   (United States)

Author keywords

hepatic metastasis; hepatocellular carcinoma; irreversible electroporation

Indexed keywords

BEVACIZUMAB; ERLOTINIB; FLUOROURACIL; SORAFENIB;

ADULT; ARTICLE; ELECTROPORATION; FEMALE; HUMAN; IRREVERSIBLE ELECTROPORATION; KAPLAN MEIER METHOD; LAPAROSCOPY; LAPAROTOMY; LIVER CELL CARCINOMA; LIVER TUMOR; LOCAL RECURRENCE FREE SURVIVAL; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL;

ABLATION TECHNIQUES; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; ELECTROPORATION; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ORGANS AT RISK; PROSPECTIVE STUDIES; REGISTRIES;

EID: 84875235955     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23280     Document Type: Article

References (28)

1. Bruix J, Llovet JM,: Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002; 35: 519-524.
2. Minami Y, Kudo M,: Radiofrequency ablation of hepatocellular carcinoma: A literature review. Int J Hepatol 2011; 2011: 104685.
3. Lencioni R,: Loco-regional treatment of hepatocellular carcinoma. Hepatology 2010; 52: 762-773.
4. Sindram D, Lau KN, Martinie JB, et al.: Hepatic tumor ablation. Surg Clin North Am 2010; 90: 863-876.
5. Shiina S, Tagawa K, Unuma T, et al.: Percutaneous ethanol injection therapy for hepatocellular carcinoma. A histopathologic study. Cancer 1991; 68: 1524-1530.
6. Livraghi T, Giorgio A, Marin G, et al.: Hepatocellular carcinoma and cirrhosis in 746 patients: Long-term results of percutaneous ethanol injection. Radiology 1995; 197: 101-108.
7. Vogl TJ, Eichler K, Straub R, et al.: Laser-induced thermotherapy of malignant liver tumors: General principals, equipment(s), procedure(s) - Side effects, complications and results. Eur J Ultrasound 2001; 13: 117-127.
8. Christophi C, Muralidharan V,: Treatment of hepatocellular carcinoma by percutaneous laser hyperthermia. J Gastroenterol Hepatol 2001; 16: 548-552.
9. Ravikumar TS, Steele GD, Jr.:, Hepatic cryosurgery. Surg Clin North Am 1989; 69: 433-440.
10. Shen HP, Gong JP, Zuo GQ,: Role of high-intensity focused ultrasound in treatment of hepatocellular carcinoma. Am Surg 2011; 77: 1496-1501.
11. Shibata T, Iimuro Y, Yamamoto Y, et al.: Small hepatocellular carcinoma: Comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology 2002; 223: 331-337.
12. Yu NC, Lu DS, Raman SS, et al.: Hepatocellular carcinoma: Microwave ablation with multiple straight and loop antenna clusters - Pilot comparison with pathologic findings. Radiology 2006; 239: 269-275.
13. O'Connor JK, Trotter J, Davis GL, et al.: Long-term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation. Liver Transpl 2012; 2: 211-215.
14. Lu DS, Yu NC, Raman SS, et al.: Radiofrequency ablation of hepatocellular carcinoma: Treatment success as defined by histologic examination of the explanted liver. Radiology 2005; 234: 954-960.
15. Komorizono Y, Oketani M, Sako K, et al.: Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer 2003; 97: 1253-1262.
16. Kim SW, Rhim H, Park M, et al.: Percutaneous radiofrequency ablation of hepatocellular carcinomas adjacent to the gallbladder with internally cooled electrodes: Assessment of safety and therapeutic efficacy. Korean J Radiol 2009; 10: 366-376.
17. Lim DH, Lee H, Park HC, et al.: The efficacy of high-dose 3-dimensional conformal radiation therapy in patients with small hepatocellular carcinoma not eligible for other local modalities. Am J Clin Oncol 2012; 4: 186-193.
18. Krishnan S, Lin EH, Gunn GB, et al.: Conformal radiotherapy of the dominant liver metastasis: A viable strategy for treatment of unresectable chemotherapy refractory colorectal cancer liver metastases. Am J Clin Oncol 2006; 29: 562-567.
19. Lee RC,: Cell injury by electric forces. Ann N Y Acad Sci 2005; 1066: 85-91.
20. Bower M, Sherwood L, Li Y, et al.: Irreversible electroporation of the pancreas: Definitive local therapy without systemic effects. J Surg Oncol 2011; 104: 22-28.
21. Maor E, Ivorra A, Leor J, et al.: The effect of irreversible electroporation on blood vessels. Technol Cancer Res Treat 2007; 6: 307-312.
22. Guo Y, Zhang Y, Klein R, et al.: Irreversible electroporation therapy in the liver: Longitudinal efficacy studies in a rat model of hepatocellular carcinoma. Cancer Res 2010; 70: 1555-1563.
23. Charpentier KP, Wolf F, Noble L, et al.: Irreversible electroporation of the liver and liver hilum in swine. HPB (Oxford) 2011; 13: 168-173.
24. Lee EW, Chen C, Prieto VE, et al.: Advanced hepatic ablation technique for creating complete cell death: Irreversible electroporation. Radiology 2010; 255: 426-433.
25. Eisenhauer EA, Therasse P, Bogaerts J, et al.: New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228-247.
26. Therneau TM, Grambsch PM, Fleming TR,: Martingale-based residuals for survival models. Biometrika 1990; 77: 147-160.
27. Bagla S, Papadouris D,: Percutaneous irreversible electroporation of surgically unresectable pancreatic cancer: A case report. J Vasc Interv Radiol 2012; 23: 142-145.
28. Thomson KR, Cheung W, Ellis SJ, et al.: Investigation of the safety of irreversible electroporation in humans. J Vasc Interv Radiol 2011; 22: 611-621.